You are on page 1of 3


Allayee H, Nitzan R, Hodis HN (2009). Polyunsaturated Fatty Acids and

Cardiovascular Disease: Implications for Nutrigenetics. J. Nutrigenetic and
Nutrigenomics. 2 : 140-148.
Chavez A, Munos C (2003). Nutrigenomics in Public Health Nutrition. European
Journal of Clinical Nutrition. 57: 97-100.
Corella, D (2009). Diet gene interactions between dietary fat intake and common
polymorphisms in determining lipid metabolism. Nutrients. 60: 22-27.
De Andrade FM, Bulhoes AC, Sharbel W, et al (2010). The Influence of
Nutrigenetics on the Lipid Profile : Interaction Between Genes and Dietary
Habits. Biochem. Genet. 48: 342-355.
Farhud DD, Yeganeh ZM (2010). Nutrigenomics and Nutrigenetics. Iranian. J.
Publ. Health. Vol : 4, 1-14.
Kussmann M (2009). Role of Proteomics in Nutrigenomics and Nutrigenetics.
Expert Rev Proteomics. 6: 453-456.
Lovegrove JA, Gitau R (2008) Nutrigenetics and CVD : what does the future
hold?. Symp. Nutr. Soc. 67: 206-213.
Minihane MA (2009). Nutrient gene interactions in lipid metabolism. Curr. Opin.
Cli. Nutr. 12: 357-363.
Minihane MA (2010). Fatty acid-genotype interactions and cardiovaskular risk.
Prostaglandins, Leukotrienes, and Essential Fatty Acids. 82: 259-264.
Muller M, Kersten S (2003). Nutrigenomics Goals and Perspectives. Nature
Review Genetic. 4: 315-22.
Mutch DM, Wahli W, Williamson G (2005). Nutrigenomics and nutrigenetics : the
emerging faces of nutrition. J. FASEB. 19: 1602-1616.
Phillips CM (2013). Nutrigenetics and Metabolic Disease: Current Status and
Implications for Personalised Nutrition. Nutrients. 5: 32-57.
Prasetyo P. Nutrigenomik dan Kesehatan. Di akses
pada tanggal 16 Oktober 2013.

Rimbach G, Minihane MA (2009). Nutrigenetics and personalised nutrition: how

far have we progressed and are we likely to get there?. Conference Nutritional
Society. 68, 162172.
Shoulders C, Kornblihtt AR, Munro BS, et al (1993). Gene structure of human
apoliporotein A1. Nuc. Aci. Res. 1983. Vol : 11.
Simopoulos AP (2010). Nutrigenetics/Nutrigenomics. Annu. Rev. Public Health.
31: 5368.
Subbiah MT (2007). Nutrigenetics and Neuraceuticals : the next wave riding on
personalized medicine. Transl. Res. 149 : 55-61.
Subbiah MT (2007). Personalizing our diet to improve our health : the potential
impact of nutrigenomics. Personalized Medicine. 3: 233-236.
Belkovets, A., Kurilovich, S., Dolgich, M. and Agarwal, D.P., 2001, Distribution
of Apolipoprotein E (ApoE) Genotypes in a Siberian Female Population Sample,
I.J.H.G., 1(3):179-182
Eichner, J.E., Terence Dunn, S., Perveen, G. and Thompson, D.M., 2002,
Apolipoprotein E Polymorphism and Cardiovascular Disease :A HuGE Review,
Am. J. Epi.,155(6):487-95
Fullerton, S.M., Clark, A.G., Weiss, K.M., Nickerson, D.A.,Taylor, S.L., Stengard,
J.H., Salomaa, V.,Vartiainen, E., Perola, M., Boerwinkle, E. and Sing, C.F., 2000,
Apolipoprotein E Variation at the Sequence Haplotype Level Implications for the
Origin and Maintenance of a Major Human, Am. J. Hum. Genet., 67:881-900
Mc Neale, P., de Knijff, P., Havekes, L.M. and Boomsma, D.I., 2000, ApoE
Polymorphism Accounts for only part of the Genetic Variation in Quantitative
ApoE Levels, Genet. Epidemiol., 18: 331340
Sima, A., Catana-Negreanu, C., Albu, R., Glavce, C. and Vladica, M., 2006,
Apoliprotein E Genotype in the Romanian Population-Association with Risk
Factors for Metabolic Syndrome, Proc. Rom. Acad., B, 1:1921
Huang, Z.H., Gu, D. and Mazzone, D., 2009 May, Role of aAdipocyte-derived
ApoE in Modulating Adipocyte Size, Lipid Metabolism and Gene Expression in
vivo, Am. J. Physiol. Endocrinol. Metab., 296(5) : E1110-9.
Sakamoto, T., Tanaka, M., Vedhachalam, C., Nickel, M., Nguyen, D.,
Dhanasekaran, P., Phillips, M.C., Lund-Katz, S., and Saito, H. 2008,
Contributions of the Carboxyl-Terminal Helical Segment to the Self-Association
and Lipoprotein Preferences of Human Apolipoprotein E3 and E4 Isoforms,
Biochemistry, 47 (9): 29682977

Irvin, M.R., Kabagambe, F.K., Tiwari, H.K., Parnel, L.D., Straka, E.J., Tsai, M.,
Ordovas, J.M., and Arnett, D.K., 2010 Oct, Apolipoprotein E Polymorphisms and
Post-prandial Triglyceridemia before and after Fenofibrate Treatment in the
Genetics of Lipid Loweringand Diet Network (GOLDN) Study, Circ. Cardiovasc.
Genet., 3(5): 362-7